Regenerative Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the regenerative medicine deals entered into by the world's leading biopharma companies.
The report provides a detailed understanding and analysis of how and why companies enter regenerative medicine deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
The report includes collaboration, development, research and licensing deals.
This report contains a comprehensive listing of 1336 regenerative medicine deals announced since 2016 including financial terms where available including links to online deal records of actual regenerative medicine partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.
The initial chapters of this report provide an orientation of regenerative medicine dealmaking.
Chapter 1 provides an introduction to the report.
Chapter 2 provides an overview of the trends in regenerative medicine dealmaking since 2019.
Chapter 3 provides an overview of the leading regenerative medicine deals since 2019. Deals are listed by headline value.
Chapter 4 provides a comprehensive listing of the top 25 most active companies in regenerative medicine dealmaking with a brief summary followed by a comprehensive listing of regenerative medicine deals, as well as contract documents available in the public domain.
Chapter 5 provides a comprehensive and detailed review of regenerative medicine deals signed and announced since Jan 2019, where a contract document is available in the public domain.
Chapter 6 provides a comprehensive and detailed review of regenerative medicine partnering deals signed and announced since Jan 2019. The chapter is organized by specific regenerative medicine technology type in focus.
The report also includes numerous table and figures that illustrate the trends and activities in regenerative medicine deal making since 2019.
In addition, a comprehensive deal directory is provided organized by company A-Z, deal type and therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
- Understand deal trends since 2019
- Browse regenerative medicine collaboration and licensing deals
- Benchmark analysis - identify market value of transactions
- Financials terms - upfront, milestone, royalties
- Directory of deals by company A-Z, deal type and therapy area
- Leading deals by value
- Most active dealmakers
- Identify assets and deal terms for each transaction
- Access contract documents - insights into deal structures
- Due diligence - assess suitability of your proposed deal terms for partner companies
- Save hundreds of hours of research time
The report provides a detailed understanding and analysis of how and why companies enter regenerative medicine deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
The report includes collaboration, development, research and licensing deals.
This report contains a comprehensive listing of 1336 regenerative medicine deals announced since 2016 including financial terms where available including links to online deal records of actual regenerative medicine partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.
The initial chapters of this report provide an orientation of regenerative medicine dealmaking.
Chapter 1 provides an introduction to the report.
Chapter 2 provides an overview of the trends in regenerative medicine dealmaking since 2019.
Chapter 3 provides an overview of the leading regenerative medicine deals since 2019. Deals are listed by headline value.
Chapter 4 provides a comprehensive listing of the top 25 most active companies in regenerative medicine dealmaking with a brief summary followed by a comprehensive listing of regenerative medicine deals, as well as contract documents available in the public domain.
Chapter 5 provides a comprehensive and detailed review of regenerative medicine deals signed and announced since Jan 2019, where a contract document is available in the public domain.
Chapter 6 provides a comprehensive and detailed review of regenerative medicine partnering deals signed and announced since Jan 2019. The chapter is organized by specific regenerative medicine technology type in focus.
The report also includes numerous table and figures that illustrate the trends and activities in regenerative medicine deal making since 2019.
In addition, a comprehensive deal directory is provided organized by company A-Z, deal type and therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
Report Scope
Regenerative Medicine Collaboration and Licensing Deals is intended to provide the reader with an in-depth understanding of regenerative medicine trends and structure of deals entered into by leading biopharma companies worldwide.Regenerative Medicine Collaboration and Licensing Deals includes:
- Trends in regenerative medicine dealmaking in the biopharma industry
- Directory of regenerative medicine deal records covering pharmaceutical and biotechnology
- The leading regenerative medicine deals by value
- Most active regenerative medicine licensing dealmakers
Analyzing contract agreements allows due diligence of:
- What are the precise rights granted or optioned?
- What is actually granted by the agreement to the partner company?
- What exclusivity is granted?
- What is the payment structure for the deal?
- How are sales and payments audited?
- What is the deal term?
- How are the key terms of the agreement defined?
- How are IPRs handled and owned?
- Who is responsible for commercialization?
- Who is responsible for development, supply, and manufacture?
- How is confidentiality and publication managed?
- How are disputes to be resolved?
- Under what conditions can the deal be terminated?
- What happens when there is a change of ownership?
- What sublicensing and subcontracting provisions have been agreed?
- Which boilerplate clauses does the company insist upon?
- Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
- Which jurisdiction does the company insist upon for agreement law?
Table of Contents
Executive SummaryChapter 1 - IntroductionChapter 6 - Regenerative medicine dealmaking by technology type
Chapter 2 - Trends in regenerative medicine dealmaking
Chapter 3 - Leading regenerative medicine deals
Chapter 4 - Most active regenerative medicine dealmakers
Chapter 5 - Regenerative medicine contracts dealmaking directory
Deal directory
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 2seventy bio
- 3D-Side
- 3D Medicines
- 3D Systems
- 3T Biosciences
- 4basebio Discovery
- 4D Molecular Therapeutics
- 180 Life Sciences
- 908 Devices
- A*STAR Agency for Science
- Technology and Research
- A*STAR’ Institute of Molecular and Cell Biology
- A2 Biotherapeutics
- AavantiBio
- AAVnerGene
- Abbvie
- AbCellera Biologics
- AbelZeta Pharma
- Abeona Therapeutics
- Abintus Bio
- ABL Bio
- Abound Bio
- Abu Dhabi Stem Cells Center
- Abveris
- Academy of Military Medical Sciences (China)
- Accelerated Biosciences
- Accelerator for Technological Research in Genomic Therapies
- Accellix
- Acepodia
- aCGT Vector
- Achilles Therapeutics
- Actinium Pharmaceuticals
- ACT Therapeutics
- ActualEyes
- Acuitas Therapeutics
- AdAlta
- Adaptimmune
- Adaptive Biotechnologies
- Adaptive Phage Therapeutics
- Adicet Bio
- Adolore Biotherapeutics
- Adva Biotechnology
- Advanced Biological Innovation and Manufacturing
- Advanced Regenerative Manufacturing Institute
- Adverum Biotechnologies
- Aegis Life
- Aethon Therapeutics
- Affimed Therapeutics
- Affini-T Therapeutics
- Affinia Therapeutics
- AffyXell Therapeutics
- Agathos Biologics
- AGC Biologics
- Ageless Biotech
- Agenus Bio
- AgeX Therapeutics
- AgonOx
- Akadeum Life Sciences
- Akouos
- Akron BioProducts
- Alaya.bio
- Albumedix
- Alder Therapeutics
- Aldevron
- Aleta Biotherapeutics
- Allele Biotechnology and Pharmaceuticals
- Allen Institute for Brain Science
- Alliance for Cancer Gene Therapy
- Alliance for Regenerative Medicine
- Allogene Overland Biopharm
- Allogene Therapeutics
- Alloplex Biotherapeutics
- AllStripes
- Almirall
- Alnylam Pharmaceuticals
- Alpha Biopharma
- Alphageneron Pharmaceuticals
- Alpha Teknova
- Alpine Immune Sciences
- Altimmune
- ALTuCELL
- Amarna Therapeutics
- American CryoStem
- American National Multiple Sclerosis Society
- American Society of Gene and Cell Therapy
- American Type Culture Collection (ATCC)
- Amgen
- Amicus Therapeutics
- AmplifyBio
- Analog Devices
- Anew Medical
- Ankarys Therapeutics
- Antengene
- Anthony Nolan
- Antion Biosciences
- Apeiron Biologics
- Apic Bio
- Apollo Therapeutics
- Appia Bio
- Applied Cells
- Applied DNA Sciences
- Applied Genetic Technologies
- Applied StemCell
- Aquitaine Science Transfert (SATT Aquitaine)
- Arbele
- Arbor Biotechnologies
- Arcellx
- Arctic Vision
- Armata Pharmaceuticals
- Armatus Bio
- Arovella Therapeutics
- Arsenal Biosciences
- Artisan Bio
- Artiva Biotherapeutics
- Aruvant Sciences
- ASC Therapeutics
- Asimov
- Asklepios Biopharmaceutical
- Aspect Biosystems
- Aspen Neuroscience
- Astellas Institute for Regenerative Medicine
- Astellas Pharma
- Astellas Pharma US
- AstraZeneca
- Atara Biotherapeutics
- Atelerix
- Athebio
- Athenex
- Athersys
- ATMPS
- ATP
- Audentes Therapeutics
- Autolomous
- Autolus
- Autonomous Therapeutics
- Avacta
- Avactis Biosciences
- Avalon GloboCare
- Avance Biosciences
- Avantor
- Avectas
- Avellino Labs
- Avery Therapeutics
- AveXis
- AviadoBio
- Avid Bioservices
- Avista Therapeutics
- Avita Therapeutics
- Avrobio
- Axcelead Drug Discovery Partners
- Axelys
- Axis Therapeutics
- AxoSim
- Axovant Gene Therapies
- Axovia Therapeutics
- B-MoGen Biotechnologies
- Banner MD Anderson Cancer Center
- Barbara Ann Karmanos Cancer Institute
- Baxter International
- Bayer
- Baylor College of Medicine
- Beam Therapeutics
- Be Biopharma
- Beckman Research Institute of City of Hope
- Beiersdorf
- BeiGene
- Belief BioMed
- Bellicum Pharmaceuticals
- Benaroya Research Institute
- Bennu Pharmaceuticals
- Berkeley Lights
- Bespoke Gene Therapy Consortium
- Be The Match BioTherapies
- Beverly Hills Cancer Center
- Bharat Biotech
- BIA Separations
- Bicycle Therapeutics
- Bill and Melinda Gates Foundation
- Bio-Techne
- BIOASTER
- BioCardia
- BioCentriq
- BioComo
- BioCurate
- BioCure
- BiocurePharm
- Biocytogen
- BioEclipse Therapeutics
- Bioelectronica
- Biogen
- Bioharmony Therapeutics
- BioInvent
- BioLab Sciences
- BioLife Solutions
- BiolineRX
- BioMagnetic Solutions
- BioMap
- BioMarin Pharmaceutical
- Biomedical Advanced Research and Development Authority
- BioMed X Innovation Center
- BiomX
- BioNex Solutions
- Bionomics
- Bionoveo
- BioNTech
- BionX Medical Technologies
- bioRASI
- BioRestorative Therapies
- Biosceptre International
- BioSenic
- Biositu Pharmaceutical Technology
- Biosolution
- BioSpherix
- BioStem Technologies
- BioTherapeutic Labs
- Biotheus
- BioVectra
- Bioventus
- BIRAD Research and Development Company
- Bird Foundation
- Bit Bio
- Blackstone
- Blood Centers of America
- Bluebird Bio
- Bluebridge Technologies
- Blueprint Genetics
- BlueRock Therapeutics
- Boehringer Ingelheim
- Bone Therapeutics
- Boyang Trading
- Brain Research Through Advancing Innovative NeurotechnologiesInitiative
- BrainStorm Cell Therapeutics
- Brammer Bio
- BriaCell Therapeutics
- BridgeBio Pharma
- Brigham and Women's Hospital
- BrightPath Biotherapeutics
- Bristol-Myers Squibb
- BRL Medicine
- Broad Institute
- Broken String Biosciences
- Brooklyn ImmunoTherapeutics
- Cabaletta Bio
- Calidi Biotherapeutics
- California Institute for Regenerative Medicine
- CAMP4 Therapeutics
- CANbridge Pharmaceuticals
- Cancer Prevention and Research Institute of Texas
- Cancer Research UK
- Candel Therapeutics
- Capricor Therapeutics
- Capsida Biotherapeutics
- Capsigen
- Captivate Bio
- Caravan Biologix
- CARB-X
- CareDx
- Caribou Biosciences
- Carina Biotech
- Caring Cross
- Carisma Therapeutics
- CARsgen
- Cartherics
- Case Western Reserve University
- CASI Pharmaceuticals
- Castle Creek Biosciences
- Catalent
- Catamaran Bio
- Catholic University Leuven
- CDISC
- Celest Therapeutics
- Celgene
- Cell-Easy
- Cell and Gene Therapy Catapult
- Cellares
- Cell Cure Neurosciences
- Cellect Biotechnology
- Cellectis
- Cellenkos
- Cellevolve Bio
- CellGenix
- Cellinfinity Bio
- CELLINK
- Cellipont Bioservices
- Cellistic
- Cell Medica
- Cell Mogrify
- Cell One Partners
- CellOrigin Biotech
- Cell Point
- CellPoint
- Celltex Therapeutics
- Cell Therapy Manufacturing Center
- Cellular Biomedicine
- Cellular Engineering Technologies
- Cellular Origins
- Cellusion
- Cell X Technologies
- Celregen
- Celsius Therapeutics
- Celularity
- Celyad
- Center for Breakthrough Medicines
- Center for Genomic Regulation
- Center for International Blood and Marrow Transplant Research
- Centre for Commercialization of Cancer Immunotherapy and Regenerative Medicine
- Centre for Commercialization of Regenerative Medicine (CCRM)
- Century Therapeutics
- Cerhum
- CERo Therapeutics
- Certara
- Cevec Pharmaceuticals
- CgBio
- CGT Global
- Champions Oncology
- Charite Universitatsmedizin Berlin
- Charles River Laboratories
- Checkpoint Therapeutics
- Children's Hospital Boston
- Children's Hospital of Philadelphia
- Children's Medical Research Institute
- Children's National Hospital
- Chimeric Therapeutics
- Chinagene Tech
- Chinese University of Hong Kong
- Cimeio Therapeutics
- Citius Pharmaceuticals
- City of Hope
- ClearPoint Neuro
- Clearside Biomedical
- Cleveland Clinic
- CMT Research Foundation
- Coalition for the Advancement of Research and Innovation in Trauma
- Coave Therapeutics
- Cobra Biologics
- CODA Biotherapeutics
- Code Biotherapeutics
- Codexis
- Codiak BioSciences
- Coeptis Therapeutics
- Cognate BioServices
- CoImmune
- Collplant
- Columbia University
- Combangio
- CombiGene
- Conkwest
- Convelo Therapeutics
- Copernicus Therapeutics
- Cornell University
- CR Double-Crane
- CRISPR Therapeutics
- Crosswalk Therapeutics
- Crown Bioscience
- CryoPort
- CSafe Global
- CSL
- CSL Behring
- CTMC
- Cue Biopharma
- Curasan
- Curate Biosciences
- Cure Duchenne
- Cure Genetics
- Curigin
- Curiox Biosystems
- Cyagen Biosciences
- Cynata Therapeutics
- Cystic Fibrosis Foundation
- Cytea Bio
- Cytiva
- Cyto-care
- CytoImmune Therapeutics
- CytoLynx Therapeutics
- CytoMed Therapeutics
- Cytoo
- CytoSen Therapeutics
- Cytovance Biologics
- Cytovant Sciences
- CYTOVIA Therapeutics
- DAAN Bio Therapeutics
- Daewoong Pharmaceutical
- Daiichi Sankyo
- Dalhousie University
- Dana-Farber Cancer Institute
- Danaher
- DanausGT Biotechnology
- Dartmouth College
- Dassault Systems
- DCM
- Decibel Therapeutics
- Deepcell
- Deep Science Ventures
- Deerfield Management
- Defense Advanced Research Projects Agency
- Defense Health Agency (US)
- Denali Therapeutics
- Dendreon
- Department of Defense
- Department of Veterans Affairs
- DermapenWorld
- Deverra Therapeutics
- Diakonos Oncology
- DigiLab
- DiNAQOR
- Diomics
- DiscGenics
- Dr. Reddy's Laboratories
- Dragonfly Therapeutics
- DTx Pharma
- Duke University
- Duoning Biotechnology
- Dyno Therapeutics
- Ecole Polytechnique de Montreal
- EdiGene
- Editas Medicine
- EditForce
- Edith Wolfson Medical Center
- eGenesis
- Egle Therapeutics
- Eikonoklastes Therapeutics
- Eledon Pharmaceuticals
- Elevai Labs
- ElevateBio
- Elicio Therapeutics
- Eligo Bioscience
- Eli Lilly
- Elixirgen
- Embleema
- Emercell
- Emory University
- Enamine
- ENCell
- Endogena Therapeutics
- Enesi Pharma
- Enlivex
- Ensoma
- Enterprise Ireland
- Entos Pharmaceuticals
- Entrada Therapeutics
- eQcell
- Erasmus University Medical Center
- ERS Genomics
- Erytech Pharma
- Eterna Therapeutics
- Ethos Discovery
- Eunice Kennedy Shriver Institute of Child Health and Human Development
- Eureka Eurostars
- Eureka Therapeutics
- European Society for Organ Transplantation
- European Union
- European Wellness Biomedical Group
- Eutilogics
- Everads Therapy
- EverCell Bio
- Evercyte
- Eversana
- Evogene
- EvolveImmune Therapeutics
- Evonetix
- Evotec
- Evox Therapeutics
- Evozyne
- Exacis Biotherapeutics
- ExcellaBio
- ExCellThera
- ExonanoRNA
- Exopharm
- Exothera
- Experimental Drug Development Centre
- Exploit Technologies
- Expression Therapeutics
- Facial Pain Research Foundation
- Factor Bioscience
- Fate Therapeutics
- Feinstein Institute for Medical Research
- Felix Biotechnology
- FerGene
- Ferring Pharmaceuticals
- FibroBiologics
- Fibrocell Science
- FibroGenesis
- FineImmune Biotechnology
- Florabio
- Florica Therapeutics
- Fluidigm
- Fondazione San Raffaele
- Fondazione Telethon
- Food and Drug Administration (FDA)
- Forcefield Therapeutics
- Forge Biologics
- Form Bio
- Forty Seven
- Fosun Pharmaceutical
- Foundation Fighting Blindness
- Foundation to Fight H-ABC
- Frametact
- Francis Crick Institute
- Fred Hutchinson Cancer Research Center
- Freeline Therapeutics
- French National Blood Service
- Fresenius Kabi Pharmaceuticals
- Friedreichs Ataxia Research Alliance
- Fujifilm
- FUJIFILM Cellular Dynamics
- Fujifilm Diosynth Biotechnologies
- Fundacion Progreso y Salud
- FutureGen Biopharm
- Gaia
- Galapagos
- Galderma
- Gallant Therapeutics
- Gamida Cell
- Gamma Biosciences
- GC Cell
- GE Healthcare
- Gemelli Teaching Hospital
- GEMMA Biotherapeutics
- GEMoaB
- Gen
- GenCure
- GeneCraft
- GenEdit
- GeneFab
- Genelux
- Genenta Science
- Genentech
- GeneQuine Biotherapeutics
- Generate Biomedicines
- Generation Bio
- Generation Biotech
- Generex Biotechnology
- Genethon
- Genevant Sciences
- Genezen
- GenKOre
- Gennao Bio
- Genome Medical
- Genosera
- Genovis
- Genpharm
- Genprex
- Gensaic
- GenScript Biotech
- GenScript ProBio
- GentiBio
- Genzyme
- Germfree
- Ghent University
- Gicell
- GigaMune
- Gilead Sciences
- Ginkgo BioWorks
- Gladstone Institutes
- Glycostem Therapeutics
- Glycotope Biotechnology
- Glytherix
- Golden Meditech
- Government of Ireland
- Gracell Biotechnologies
- Gradalis
- Graphite Bio
- Green Cross LabCell
- Greenlight Biosciences
- Gritstone Bio
- Grunenthal
- GSK
- GT Biopharma
- Guangzhou Fanen Biotechnology
- Gyroscope Therapeutics
- Hadassah Medical Center
- HaemaLogiX
- Haihe Laboratory of Cell Ecosystem
- HanAll Pharmaceuticals
- Hangzhou CNK Therapeutics
- Hannover Medical School
- Hansa Biopharma
- Hanuman Pelican
- Harbour Biomed
- Harvard University
- HCW Biologics
- Healios K.K.
- Heartseed
- Heat Biologics
- HebeCell
- Hebrew University of Jerusalem
- Helmholtz Zentrum Munchen
- Hemera Biosciences
- Hemostemix
- HepaTx
- Hitachi
- Hitachi Chemical
- Hitech Health
- HK inno.N
- Hong Kong Baptist University
- Hopstem Biotechnology
- Horama
- Horizon Europe
- Hoth Therapeutics
- Houston Methodist Research Institute
- Huadong Medicine
- HuidaGene Therapeutics
- Humacyte
- Humanigen
- Hunterian Medicine
- Hypertrust
- IASO Biotherapeutics
- Iaso Pharmaceuticals
- Iaso Therapeutics
- Icahn School of Medicine at Mount Sinai
- iECURE
- IGEA Clinical Biophysics
- Ikarovec
- Imagine Pharmaceuticals
- Immatics Biotechnologies
- Immix Biopharma
- ImmPACT Bio
- Immunai
- Immunis
- ImmunityBio
- ImmunoAdoptive Cell Therapy
- ImmunoChina Pharmaceuticals
- Immunomic Therapeutics
- ImmunoScape
- ImmunXperts
- Immusoft
- ImmVira
- Imperial College London
- Implant Therapeutics
- Imugene
- IMV
- Inceptor Bio
- Incyte
- Indapta Therapeutics
- Indee Labs
- Inhibrx
- INmune Bio
- InnDura Therapeutics
- InnoBation
- Innovare
- Innovate UK
- Innovent Biologics
- InProTher
- Inscripta
- Insitro
- Instem
- Institute of Endocrinology
- Metabolism
- and Reproduction
- Institute of Molecular and Clinical Ophthalmology Basel
- Institute of Neurodegenerative Diseases
- Instituto de Biologia Experimental e Tecnológica
- Institut Pasteur
- Integral Molecular
- Integra Therapeutics
- Inteligex
- Intellia Therapeutics
- Interbiome
- Intima Bioscience
- Intrexon
- iNtRON Biotechnology
- Invectys
- Invetech
- Invitae
- INVO Bioscience
- Ionis Pharmaceuticals
- Iovance Biotherapeutics
- I Peace
- IQVIA
- IsoPlexis
- iSpecimen
- Israeli National Authority for Technological Innovation
- Itochu
- iTolerance
- Iveric Bio
- iVexSol
- Ixaka
- Jacobio Pharmaceuticals
- Janssen Biotech
- Janssen Pharmaceuticals
- Janssen Pharmaceutica NV
- Janssen Research & Development
- Jasper Therapeutics
- JCR Pharmaceuticals
- jCyte
- Jenner Institute
- Jiangsu Hengrui Pharmaceuticals
- Johns Hopkins University
- Josep Carreras Leukaemia Research Institute
- JSR
- Juniper Biologics
- Juno Therapeutics
- Jura Bio
- Juvenile Diabetes Research Foundation
- Juventas Therapeutics
- JW Therapeutics
- Kadimastem
- KaliVir Immunotherapeutics
- Karolinska Institute
- Karolinska University Hospital
- Kate Therapeutics
- Keck School of Medicine of USC
- Kelonia Therapeutics
- Kennedy Institute of Rheumatology
- Kentucky Organ Donor Affiliates
- Keraderm
- Kiadis Pharma
- Kidswell Bio
- Kincell Bio
- Kinesiometrics
- Kings College London
- Kiromic Biopharma
- Kite Pharma
- Kleo Pharmaceuticals
- Kolon Life Science
- Kriya Therapeutics
- KromaTiD
- KSQ Therapeutics
- Kumamoto University
- Kytopen
- Kyverna Therapeutics
- L7 Informatics
- LabConnect
- Laboratoires Thea
- Laboratory Corporation of America
- Lacerta Therapeutics
- Landmark Bio
- Lantheus Holding
- Lee Moffitt Cancer Center
- Legend Biotech
- Leibniz-Institut fur Molekulare Pharmakologie
- Leiden University
- Leidos
- Leucid Bio
- Leukocare
- LEXEO Therapeutics
- LG Chem
- LG Life Sciences
- LifeSprout
- LIfT BioSciences
- Ligandal
- Likarda
- Lineage Cell Therapeutics
- Link Health
- Lion TCR
- Locana
- Locate Bio
- Locus Biosciences
- LogicBio Therapeutics
- Logomix
- Longeveron
- Long Island University
- Lonza
- LUCA Science
- Lucy Biotech
- Lukas Biomedical
- Luminary Therapeutics
- Lung Biotechnology
- Lupagen
- Lupus Therapeutics
- Lyell Immunopharma
- LyGenesis
- Lykan Bioscience
- Lysogene
- Lytix Biopharma
- Maastricht University
- Macomics
- Magenta Therapeutics
- MainPointe
- Mammoth Biosciences
- Marasco Laboratory
- Marker Therapeutics
- Mark Foundation for Cancer Research
- Massachusetts Eye and Ear Infirmary
- Massachusetts General Hospital
- Massachusetts Institute of Technology
- Mass General Brigham
- MaSTherCell
- Matica Biotechnology
- Mawson Infrastructure
- Max-Planck
- Maxcyte
- Mayo Clinic
- McKesson
- McMaster University
- MCQ Instruments
- MD Anderson Cancer Center
- MDA Venture Philanthropy
- MDimune
- Medac
- Medexus Pharmaceuticals
- Medgenics
- Medical University of South Carolina
- MediciNova
- Medigen Biotechnology
- MediGene
- Medigen Vaccine Biologics
- MedImmune
- MED Institute
- Medipal Holdings
- MediSix Therapeutics
- MeiraGTx
- Mekonos
- Memorial Sloan Kettering Cancer Center
- Mendus
- Merck and Co
- Merck KGaA
- Mesoblast
- Metagenomi
- Michael J Fox Foundation
- Michal Morrison
- Microbio Shanghai
- Microsoft
- Mie University
- MIGAL Galilee Research Institute
- MilliporeSigma
- Miltenyi Biotec
- MiMedx
- Minaris Regenerative Medicine
- MiNA Therapeutics
- Minerva Biotechnologies
- MiNK Therapeutics
- Minovia Therapeutics
- Miromatrix Medical
- Mirum Pharmaceuticals
- Mission Bio
- Mitacs
- MitoSense
- Mitsubishi Tanabe Pharma
- Modalis Therapeutics
- Moderna
- Molecular Templates
- Moligo Technologies
- MolMed
- Mongoose Bio
- Monomer Bio
- Morgenesis
- MorphoSys
- Mosaic ImmunoEngineering
- Mount Sinai Health System
- Mount Sinai Medical Center
- MSD
- mSKIL
- MTF Biologics
- Multimmune
- Multiple Myeloma Research Foundation
- Multiply Labs
- Mundipharma
- Murdoch Childrens Research Institute
- Muscular Dystrophy Association
- Mustang Bio
- Myeloid Therapeutics
- myNEO
- Myrtelle
- myTomorrows
- Nagoya University Graduate School of Medicine
- Namocell
- NanoCellect Biomedica
- Nanommune
- Nanoscope Therapeutics
- NanoString Technologies
- Nanotronics Health
- NanoVation Therapeutics
- NantKwest
- NantOmics
- NASA
- NATA
- National Cancer Institute
- National Center for Advancing Translational Sciences (NCATS)
- National Eye Institute
- National Heart
- Lung and Blood Institute
- National Human Genome Research Institute
- National Institute for Bioprocessing Research and Training
- National Institute for Innovation in Manufacturing Biopharmaceuticals
- National Institute of Allergy and Infectious Diseases
- National Institute of Arthritis and Musculoskeletal Diseases
- National Institute of Dental and Craniofacial Research (NIDCR)
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institute of Mental Health
- National Institute of Neurological Disorders and Stroke
- National Institute on Deafness and Other Communication Disorders
- National Institute on Drug Abuse (NIDA)
- National Institutes of Health
- National Organization for Rare Disorders
- National Research Council Canada
- National Research Council of Canada
- National Resilience
- National Science Foundation
- National University of Ireland
- Galway (NUI Galway)
- National University of Singapore
- Nationwide Children’s Hospital
- NAYA Biosciences
- Ncardia
- NEC
- NecstGen
- Nektar Therapeutics
- Neo Gene Pharm
- Neogene Therapeutics
- NeoImmuneTech
- NeuExcell
- Neukio Biotherapeutics
- Neuracle Genetics
- Neurgain Technologies
- Neurimmune Therapeutics
- Neurochase
- Neurocrine Biosciences
- Neurogene
- Neurona Therapeutics
- Neurophth Therapeutics
- NewBiologix
- New Jersey Innovation Institute
- Newsoara Biopharma
- New York Blood Center
- Nexcella
- Nexel
- Neximmune
- Next&Bio
- Next Generation Manufacturing Canada
- Nippon Shinyaku
- Nkarta Therapeutics
- NKGen Biotech
- NKMax America
- Noga Therapeutics
- Noile-Immune Biotech
- Nona Biosciences
- Nordic Nanovector
- North Carolina State University
- Northeastern University
- Northern Biomedical Research
- Northern RNA
- Northwell Health
- Northwestern University
- NorthX Biologics
- Notch Therapeutics
- NovaBay Pharmaceuticals
- Novartis
- Novartis Institutes for BioMedical Research
- Novasep
- NoveCite
- Novellus Biopharma
- Novellus Therapeutics
- Novo Nordisk
- Nucleus Biologics
- NurExone Biologic
- Nvidia
- NysnoBio
- NYU Langone Medical Center
- Obio
- Obsidian Therapeutics
- Ochre Bio
- Octomera
- Ocugen
- Oculogenex
- Ocumension Therapeutics
- Odylia Therapeutics
- Ohio State University
- Omeros
- OmniaBio
- Oncora Medical
- OncoSec Medical
- Oncternal Therapeutics
- Oneness Biotech
- ONI
- oNKo-innate
- ONK Therapeutics
- Ono Pharmaceutical
- Ontario Institute for Regenerative Medicine
- Onward Therapeutics
- Ophthotech
- Opsis Therapeutics
- Optieum Biotechnologies
- Optimeos Life Sciences
- Opus Genetics
- Orbit Biomedical
- Orca Bio
- Orchard Therapeutics
- Organovo
- Orgenesis
- Ori Biotech
- Orthofix Medical
- Ortho Regenerative Technologies
- OSE Immunotherapeutics
- OSR Holdings
- Osteopore International
- Oswaldo Cruz Foundation (Fiocruz)
- Otsuka
- Outpace Bio
- Overland Pharmaceuticals
- Ovid Therapeutics
- Oxford BioMedica
- Oxford Genetics
- Oxgene
- Oyster Point Pharma
- PACT Pharma
- Palantir
- Pall Corporation
- Panbela Therapeutics
- panCELLa
- Pancryos
- Papyrus Therapeutics
- Parent Project Muscular Dystrophy
- Parkinsons Disease Foundation
- Passage Bio
- PDC*line Pharma
- PDS Biotechnology
- Penn Medicine
- Perelman School of Medicine
- PersonGen BioTherapeutics
- Peter MacCallum Cancer Institute
- Pfizer
- Phagelux
- Phanes Therapeutics
- PharmaCyte Biotech
- PharmaEssentia
- Pharmsynthez
- Phenomic AI
- Pherecydes Pharma
- Phibro Animal Health
- Phio Pharmaceuticals
- PhoreMost
- Pierre Fabre
- Plastomics
- Platelet BioGenesis
- Pluri
- Pluristem Therapeutics
- Pluristyx
- Polyplus Transfection
- Pompeu Fabra University
- Portage Biotech
- Poseida Therapeutics
- PreCerv
- Precision BioSciences
- PrecisionLife
- Precision NanoSystems
- Precision Virologics
- Predictive Oncology
- Pregene Biopharma
- Prevail Therapeutics
- Prime Medicine
- ProBioGen
- Procyon Technologies
- ProMab Biotechnologies
- Promethera Biosciences
- ProteinTech
- Proteona
- ProteoNic
- Providence Cancer Institute
- PTC Therapeutics
- Pulthera
- Pure MHC
- Purespring Therapeutics
- Q-Gen Cell Therapeutics
- Qilu Pharmaceutical
- Quebec Consortium for Drug Discovery
- Queen Mary University of London
- Queensland Institute of Medical Research (QIMR)
- Quell Therapeutics
- R4D Biotech
- rAAVen Therapeutics
- Ray Therapeutics
- RCSI University of Medicine and Health Sciences
- ReCode Therapeutics
- Refreshgene Therapeutics
- Refuge Biotechnologies
- Regeneron Pharmaceuticals
- Regenexx
- RegenLab
- Regenxbio
- ReiThera
- Rejuvenate Bio
- Remedium Bio
- ReNeuron
- Renovacare
- RenovoRx
- Rentschler Biotechnologie
- Replay
- Replicel Life Sciences
- Rescue Hearing
- Research Products Development Company
- Resilience
- Resolution Therapeutics
- Rexgenero
- Reyon Pharmaceuticals
- Rice University
- Ricoh
- Rigenerand
- RIKEN Yokohama Institute Omics Science Center
- RION
- Rivaara Immune
- Roche
- Rocket Pharmaceuticals
- Rokote Laboratories
- RoosterBio
- Roswell Park Cancer Institute
- Royal Children’s Hospital
- Rubedo Life Sciences
- Rune Labs
- Russian Direct Investment Fund
- Rutgers University
- RxCell
- Rznomics
- Sana Biotechnology
- SanBio
- Sangamo Therapeutics
- Sanofi
- Santen Pharmaceutical
- Santhera Pharmaceuticals
- Sant Joan de Déu-Barcelona Children’s Hospital
- Sapreme Technologies
- Sarah Cannon Research Institute
- Sarepta Therapeutics
- Sartorius
- Sartorius Stedim Biotech
- SATT Conectus Alsace
- ScaleReady
- Scenic Biotech
- SCM Pharma
- Scopus BioPharma
- Scribe Therapeutics
- Scripps Research Institute
- Scriptr Global
- SCTbio
- Seattle Children's Hospital
- Seattle Children's Therapeutics
- Seattle Childrens Research Institute
- Seelos Therapeutics
- Selecta Biosciences
- Selexis
- Sensei Biotherapeutics
- Sensorion
- Senti Biosciences
- Seoul National University
- SeQure Dx
- Seraxis
- Sernova
- Serotiny
- Sexton Biotechnologies
- Shanghai Cell Therapy Group
- Shanghai Medicilon
- Shape Therapeutics
- Shinshu University
- Shoreline Biosciences
- Showa Denko
- Sigilon Therapeutics
- SillaJen
- Simcha Therapeutics
- SimonMed Imaging
- Singapore Eye Research Institute (SERI)
- Sino Biological
- Sinorda Biomedicine
- Siren Biotechnology
- Sirion Biotech
- Sirtex Medical
- SiSaf
- SK Pharmteco
- Skyline Therapeutics
- Smart Immune
- SmartPharm Therapeutics
- Sofregen Medical
- Solentim
- Solid Biosciences
- Solve GNE
- Somite Therapeutics
- Sonnet BioTherapeutics
- Sonoma BioTherapeutics
- SonoThera
- Sony
- Sorrento Therapeutics
- Spanish State Research Agency
- SparingVision
- Spark Therapeutics
- SparX Biopharmaceutical
- Sphere Fluidics
- Spinogenix
- SpliceBio
- SpringWorks Therapeutics
- SQZ Biotech
- Stanford University
- StemCardia
- Stemedica Cell Technologies
- Stem Genomics
- StrideBio
- Strm.Bio
- SUDA Pharmaceuticals
- Summit Biosciences
- Supercell Biotechnology
- Surrozen
- Suzhou Porton Advanced Solutions
- SwanBio Therapeutics
- Syena
- Symbasis
- Symbiosis
- Symvivo
- Synlogic
- Synova Healthcare
- Synplogen
- Synthego
- T-Cure Bioscience
- T-MAXIMUM Biotech
- TaiwanBio Therapeutics
- Takara Bio
- Takeda Pharmaceutical
- Takeda Ventures
- Talaris Therapeutics
- Talee Bio
- Tantu Therapeutics
- Targovax
- Taysha Gene Therapies
- TC BioPharm
- TCR2 Therapeutics
- TeamedOn International
- Tel Aviv Sourasky Medical Center
- TeneoBio
- Terumo Blood and Cell Technologies
- Tessa Therapeutics
- Tetherex Pharmaceuticals
- Tevard Biosciences
- Tevogen Bio
- Texas A&M Health Science Center
- Texcell
- TFF Pharmaceuticals
- TGen Drug Development
- TG Therapeutics
- The Native Antigen Company
- The New York Stem Cell Foundation
- The Parker Institute For Cancer Immunotherapy
- Therabest
- Theracell
- Theradaptive
- Theragent
- Therapeutic Solutions International
- Theravectys
- Theriva Biologics
- Thermo Fisher Scientific
- ThinkCyte
- Thomas Jefferson University
- Thought Leadership & Innovation Foundation
- Tianjin CanSino Biotechnology
- TILT Biotherapeutics
- Tiziana Life Sciences
- T Med
- Tmunity Therapeutics
- Tome Biosciences
- TOMI Environmental Solutions
- TONIX Pharmaceuticals
- Toregem BioPharma
- Torque Therapeutics
- Toshiba
- Trakcel
- Transgene
- TreeFrog Therapeutics
- Trestle Biotherapeutics
- TriMetis Life Sciences
- Trinity College Dublin
- Triumvira Immunologics
- Truveta
- TScan Therapeutics
- Tufts University
- Turnstone Biologics
- Twist Bioscience
- Tyris Therapeutics
- U CAN-CER VIVE Foundation
- UCB
- UCL Business
- Ultragenyx Pharmaceuticals
- Umoja Biopharma
- UniQure
- United Therapeutics
- Univercells
- Universal Cells
- Universite Laval
- University College London
- University of Barcelona
- University of Basel
- University of California
- Davis
- University of California Berkeley
- University of California Irvine
- University of California San Francisco
- University of California Santa Barbara
- University of Chicago
- University of Colorado
- University of Eastern Finland
- University of Edinburgh
- University of Florida
- University of Florida Research Foundation
- University of Heidelberg
- University of Helsinki
- University of Manchester
- University of Massachusetts Medical School
- University of Miami
- University of Minnesota
- University of Missouri
- University of Montreal
- University of North Carolina
- University of Oxford
- University of Pennsylvania
- University of Pennsylvania School of Veterinary Medicine
- University of Pittsburgh
- University of Quebec
- University of Sheffield
- University of South Australia
- University of Southern California
- University of Technology Sydney
- University of Texas
- University of Texas Southwestern Medical Center
- University of Washington
- US Army
- US Army Medical Research Institute of Chemical Defense
- Utrecht University
- UT Southwestern Medical Center
- Vaccinex
- Valitacell
- Valo Therapeutics
- Vanderbilt University
- Vaxalto Biotherapeutics
- Vaximm
- Vector BioMed
- Vector BioPharma
- VectorBuilder
- VectorY Therapeutics
- Velabs Therapeutics
- Veltmeyer MD
- Verily
- Verismo Therapeutics
- Vertex Pharmaceuticals
- Vesigen Therapeutics
- ViaCyte
- Victoria University
- Vigene Biosciences
- ViGeneron
- Vineti
- Viralgen
- Vir Biotechnology
- Virica Biotech
- Virion Therapeutics
- Viroclinics Biosciences
- Vision Care Group
- Vittoria Biotherapeutics
- VIVEbiotech
- Vivet Therapeutics
- VolitionRX
- Vor Biopharma
- Voyager Therapeutics
- Vycellix
- Vyriad
- Wageningen University
- Wake Forest Institute for Regenerative Medicine
- Wake Forest University
- Walking Fish Therapeutics
- Walloon Region Investment Fund
- Walter Reed Army Institute of Research
- Washington University in St Louis
- WCTE
- Weizmann Institute
- Werum IT Solutions
- WhiteLab Genomics
- WindMIL Therapeutics
- Wisconsin Alumni Research Foundation
- Wiseman Cancer Research Foundation
- Wistar Institute
- W L Gore
- WUGEN
- WuXi Advanced Therapies
- Wuxi Apptec Laboratory Services
- WuXi Biologics
- Xcell Biosciences
- Xencor
- Xenetic Biosciences
- Xilio Therapeutics
- Xlife Sciences
- XNK Therapeutics
- Xylyx Bio
- Xyphos Biosciences
- Y-Biologics
- Yale Cancer Center
- Yale University
- YASKAWA Electric
- Yeda Research and Development Company
- Yinjia Biosciences
- Yissum Research Development
- Yposkesi
- Yufan Biotechnologies
- Zelluna Immunotherapy
- Ziopharm Oncology
- Zogenix
Methodology
- The publisher reports provide insight into the trends and terms of partnering deals in the global life sciences sector.
- The publisher reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.
- The publisher analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.
- The publisher reports source deal data from our proprietary deals and alliances database. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal.
- The data in the deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.
The publisher provides comprehensive coverage of the following partnering or deal types:
- Asset purchase
- Assignment
- Co-development
- Co-market
- Co-promotion
- Collaborative R&D
- Contract service
- CRADA
- Cross-licensing
- Development
- Distribution
- Equity purchase
- Evaluation
- Grant
- Joint venture
- Licensing
- Loan
- Manufacturing
- Marketing
- Option
- Promotion
- Research
- Royalty financing
- Settlement
- Spin out
- Sub license
- Supply
- Termination
- Warrant
Every deal record is fully categorized and includes the following data, where available:
- Industry sector
- Therapy areas
- Technology type
- Deal components
- Financial terms
- Stage of development
- Exclusivity
- Asset type
- Geographic focus
- Excluded geography
- Company press release
- SEC filing data including contract document
All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.
LOADING...